Latest Financial Performance News

hipages Group (ASX:HPG) has kicked off an on-market buy-back of up to 10% of its shares, signalling confidence in its undervalued stock amid strong cash flow and growth.

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

Vection Technologies has reported its third straight quarter of positive operating cash flow, driven by a $30 million Defence order book and a surge in AI contracts worth $4 million across multiple sectors.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Peak Processing reported its first positive EBITDA month in March 2026, driven by operational efficiencies and strong production growth. The company upgraded its Q4 production forecast and expanded key customer contracts, signaling a turning point after a challenging period.

Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

RocketDNA Ltd delivered a break-even operating cash flow quarter with $2.47 million revenue, driven by soaring autonomous drone usage and the debut of its Skylink® operating system.

Capricorn Metals produced 30,358 ounces of gold in Q3 at Karlawinda, progressing its expansion project on schedule and declaring a maiden dividend, while exploration at Mt Gibson reveals promising underground gold extensions.

Parkway Corporate Limited delivered a record $5.21 million quarterly revenue and $0.73 million EBITDA in Q3 FY26, driven by ramp-up of a major water infrastructure project. Meanwhile, its flagship Queensland Brine Management Complex progresses through key development application milestones with public notification underway.

Image Resources delivered a solid first quarter at its Atlas project with production and sales within guidance, operating costs under forecast, and secured a six-month debt repayment holiday. Development advances on multiple mineral sands projects and maiden gold resource drilling is underway.